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Diversity of vaginal microbiome 
and metabolome during genital 
infections
camilla ceccarani1,2, Claudio foschi  3, Carola parolin  4, Antonietta D’Antuono5, 
Valeria Gaspari5, Clarissa consolandi1, Luca Laghi  6, Tania camboni1, Beatrice Vitali  4, 
Marco Severgnini  1 & Antonella Marangoni  3
We characterized the vaginal ecosystem during common infections of the female genital tract, as 
vulvovaginal candidiasis (VVC, n = 18) and Chlamydia trachomatis infection (CT, n = 20), recruiting 
healthy (HC, n = 21) and bacterial vaginosis-affected (BV, n = 20) women as references of eubiosis and 
dysbiosis. The profiles of the vaginal microbiome and metabolome were studied in 79 reproductive-
aged women, by means of next generation sequencing and proton based-nuclear magnetic resonance 
spectroscopy. Lactobacillus genus was profoundly depleted in all the genital infections herein 
considered, and species-level analysis revealed that healthy vaginal microbiome was dominated by 
L. crispatus. In the shift from HC to CT, VVC, and BV, L. crispatus was progressively replaced by L. 
iners. CT infection and VVC, as well as BV condition, were mainly characterised by anaerobe genera, 
e.g. Gardnerella, Prevotella, Megasphaera, Roseburia and Atopobium. the changes in the bacterial 
communities occurring during the genital infections resulted in significant alterations in the vaginal 
metabolites composition, being the decrease of lactate a common marker of all the pathological 
conditions. In conclusion, according to the taxonomic and metabolomics analysis, we found that each 
of the four conditions is characterized by a peculiar vaginal microbiome/metabolome fingerprint.
The cervicovaginal ecosystem is made up of diverse microorganisms coexisting in a dynamic balance and estab-
lishing complex connections with each other and with the host. In healthy reproductive-aged women, the vaginal 
microbiome, generally, shows a predominance of Lactobacillus genus, and most women display the prevalence 
of one species among L. crispatus, L. iners, L. jensenii and L. gasseri1. Lactobacilli promote the maintenance of 
the vaginal homeostasis and prevent the colonization and growth of adverse microorganisms, including those 
responsible for sexually transmitted infections (STIs). Such defensive function is exerted through various mech-
anisms, such as vaginal pH lowering, bioactive compounds production, competition for nutrients and adhesion 
sites, and modulation of host immune response2–5. However, the composition of the vaginal microbiome can vary 
throughout a woman’s life in response to endogenous and exogenous factors, such as age, pregnancy, pharmaceu-
tical treatments, and urogenital infections.
Urogenital infections and dysbiosis afflict over 1 billion women each year, compromising their wellbeing and 
affecting their reproductive health6. The most common vaginal dysbiosis worldwide is bacterial vaginosis (BV), 
which is characterized by a shift in the microbial composition from the normally Lactobacillus-dominated to a 
high-complexity, polymicrobial community. It has been largely established that BV condition is characterized 
by the presence of anaerobic bacteria, such as Gardnerella vaginalis, Atopobium spp., Prevotella spp., and high 
concentrations of various biogenic amines (putrescine, cadaverine and trimethylamine), short chain fatty acids 
(especially acetate and succinate) and low levels of some amino acids (tyrosine, glutamate)7–9. In several epidemi-
ological studies it has been reported that BV represents a risk factor for the acquisition of STIs10,11.
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Among infections, vulvovaginal candidiasis (VVC) affects about 75% of reproductive-aged women at least 
once during their lives, with about 5% of them suffering of recurrences12. VVC is caused by Candida spp. which, 
in particular conditions, instead of being part of the normal vaginal microflora, become a robust opportunistic 
fungal pathogen, with a tendency to overgrow13. C. albicans is responsible for 80–92% of VVC cases. The causes 
and phases of the transition from the homeostasis to the pathogenic state of VVC are not clear yet, as well as the 
impact, if any, on the vaginal microbiome structure and metabolomic profile.
Chlamydia trachomatis (CT) represents the most common bacterial STI worldwide, and new infections prob-
ably exceed 131 million per year14. CT is a Gram-negative, obligate intracellular bacterial pathogen with a unique 
biphasic developmental cycle15. CT serovars from D to K are responsible for common and frequently asympto-
matic urogenital infections (i.e. urethritis and cervicitis), that may lead to several sequelae and complications, 
including pelvic inflammatory disease (PID), ectopic pregnancy, and infertility. Globally, serovars E, F, D, and G 
represent the most common serovars, accounting for 60–80% of cases16,17. Given its high prevalence and socio-
logical impact, correlation of CT infection with the cervico-vaginal microbiome has recently gained particular 
attention: some cross-sectional studies have been published18,19, and vaginal microbiome/metabolome finger-
prints have been explored20.
In this work, we depicted and compared the alterations that occur in the vaginal microbiome and metabolome 
during common genital infections. Two high-performing techniques, i.e. next generation sequencing (NGS) and 
proton-based nuclear magnetic resonance (1H-NMR) spectroscopy, were applied to unravel the vaginal micro-
biome composition and the metabolome fingerprint, respectively, highlighting common trends and correlations. 
The relatively-less characterized ecosystems corresponding to VVC and CT infection were compared to the 
healthy status (reference of eubiosis) and BV condition (reference of dysbiosis).
Results
Study group. A total of 79 patients were included in the study: specifically, 21 were considered healthy (HC), 
20 received a diagnosis of bacterial vaginosis (BV), 20 had a C. trachomatis genital infection (CT) and 18 suffered 
from vulvo-vaginal candidiasis (VVC) due to C. albicans. Clinical and demographic information of the study 
groups are reported in details in Table 1. No significant differences were found in the age distribution between the 
different groups of women. Most of the HC and CT-positive women showed a Nugent score 0–3 (76% and 65%, 
respectively), while 60% of BV subjects were characterised by a Nugent score >7. Women in the VVC group had 
an intermediate condition (Nugent score 4–6) in 61% of cases. A creamy gray discharge was referred by 85% of 
BV patients, whereas all subjects suffering from VVC complained from itching and/or whitish discharge. More 
than half (11/20; 55%) of CT-positive patients were completely asymptomatic. The most common CT serovar in 
our population was E (11/20; 55%), followed by F (4/20; 20%), G (2/20; 10%), D (2/20; 10%) and K (1/20; 5%).
Vaginal microbiota structure characterization. DNA extracted from vaginal swabs was subjected to 
next generation sequencing of the V3-V4 hypervariable regions of 16S rRNA gene, which produced an average 
of 56,273 reads per sample. Alpha-diversity analysis using Shannon index metrics showed significant differences 
in biodiversity among the four groups (Kruskal-Wallis p-value < 0.001, Fig. 1a). In particular, BV samples were 
characterised by a significant higher microbiota diversity compared to HC (p = 0.006) and CT (p = 0.006) groups; 
the comparison between HC and BV resulted significant with the Chao1 index as well (p = 0.024). No significant 
differences were observed with the other metrics used (observed species and Faith’s phylogenetic diversity index).
Beta-diversity analysis highlighted that each condition was characterized by a peculiar microbiota: principal 
coordinates analysis (PCoA) showed a significant segregation of the four women groups (adonis p-value < 0.001, 
on both weighted and unweighted Unifrac distances, Fig. 1b). Moreover, a significant separation on unweighted 
Unifrac distance was evidenced for all pairwise comparisons (all p-values < 0.05), being BV the most profoundly 
HC (N = 21) BV (N = 20) CT (N = 20) VVC (N = 18) P
Enrolment criteria No symptoms and negative for microbiological tests
Positive for 3/4 Amsel criteria
and Nugent score > 3
Vaginal detection of 
CT DNA by NAAT
Suggestive symptoms and 
detection of C. albicans —
Mean age ± SD (years) 26.1 ± 6.3 29.3 ± 7.7 24.3 ± 3.4 27.8 ± 7.2 0.08
Mean BMI ± SD (kg/m2) 23.8 ± 2.4 22.9 ± 2.4 23.6 ± 1.8 23.0 ± 2.0 0.38
Amsel criteria
Creamy gray discharge 0/21 (0.0%) 17/20 (85.0%) 0/20 (0.0%) 0/18 (0.0%) <0.0001
Mean vaginal pH value 4.1 ± 0.3 4.8 ± 0.4 4.2 ± 0.4 4.3 ± 0.5 <0.0001
Positive Whiff testa 5/21 (23.8%) 10/20 (50.0%) 4/20 (20.0%) 3/18 (16.7%) 0.07
Clue cells present 1/21 (4.7%) 19/20 (95.0%) 3/20 (15.0%) 5/18 (27.8%) <0.0001
Nugent score
0–3 16/21 (76.2%) 0/20 (0.0%) 13/20 (65.0%) 7/18 (38.9%) <0.0001
4–6 5/21 (23.8%) 8/20 (40.0%) 7/20 (35.0%) 11/18 (61.1%) 0.11
7–10 0/21 (0.0%) 12/20 (60.0%) 0/20 (0.0%) 0/18 (0.0%) <0.001
Table 1. Demographic and clinical characteristics of the women enrolled for the study, subdivided in healthy 
(HC), bacterial vaginosis (BV), C. trachomatis (CT), and vulvo-vaginal candidiasis (VVC) groups. aThe Whiff 
test is considered positive when, by adding a drop of 10% KOH to a microscopic slide containing the vaginal 
secretions, a characteristic ‘fishy’ odour is present.
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different condition compared to the others. Weighted Unifrac distances analysis confirmed that HC and BV pos-
sessed a unique microbial composition (all pairwise comparison p-values < 0.05), whereas VVC and CT condi-
tions, although different from the other two experimental groups, did not show a significant separation between 
them (p = 0.34). Moreover, within the CT-infected group, no significances were observed, in both alpha and 
beta diversities, according to Chlamydia serotype (serovar E: 11 patients; non-E, including serovars F, G, D, K: 9 
patients).
Taxonomic composition of vaginal bacterial communities. Analyzing taxonomic classification 
at the phylum level, it was found that all samples were mainly constituted by Firmicutes, Actinobacteria, and 
Bacteroidetes, although with many significant differences in their abundances across groups (all Kruskal-Wallis 
p-values < 0.001, Fig. 2a). Firmicutes dominated the vaginal microbiota of all women groups, with abundance 
ranging from 92.4% in HC, to 60.6% in BV-affected women. Besides BV, also VVC-infected women (79.2%), 
but not CT subjects (89.8%) were significantly depleted in Firmicutes. In contrast, Actinobacteria were signif-
icantly more abundant in BV (18.4%), and VVC (12.0%) groups with respect to HC (3.4%) and CT (5.6%). A 
similar observation was made for Bacteroidetes phylum, which represents 11.5% of abundance in BV women, 
5.0% in VVC and only 2.7% and 3.0% in HC and CT subjects, respectively. Fusobacteria phylum was significantly 
enriched only in BV samples (7.9%), while Proteobacteria mainly characterized the VVC group (2.2%).
Figure 1. Structure of the vaginal microbiota. Microbial composition of vaginal swabs of healthy (HC), C. 
trachomatis (CT), vulvo-vaginal candidiasis (VVC) and bacterial vaginosis (BV) positive women was analysed. 
(a) Boxplots of Shannon index (α-diversity). (b) Principal Coordinates Analysis (PCoA) plot based on 
unweighted Unifrac distance (β-diversity). Each point corresponds to a sample. For each experimental class, 
the SEM-based confidence ellipse around the centroid is depicted. The first two components of the variance are 
represented.
Figure 2. Taxonomic composition of the vaginal microbiota. Stacked bar charts of taxonomy relative 
abundances at (a) phylum and (b) genus level for healthy (HC), C. trachomatis (CT), vulvo-vaginal candidiasis 
(VVC) and bacterial vaginosis (BV) positive subjects. Only phyla and genera present at relative abundances 
>1% in at least 20% (i.e.: ≥16 samples) are reported. Remaining taxa are grouped in the “Other” category.
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Level Group
Relative abundance P-value
HC (%) CT (%) VVC (%) BV (%) Overalla CT vs. HCb VVC vs. HCb BV vs. HCb
Phylum
↓ Firmicutes 92.41 89.78 79.22 60.61 <0.001 — 0.004 <0.001
↑ Actinobacteria 3.39 5.62 12.02 18.38 <0.001 — <0.001 <0.001
↑ Bacteroidetes 2.71 2.99 5.02 11.51 <0.001 — 0.019 <0.001
↑ Fusobacteria 0.22 0.42 0.54 7.87 0.003 — — <0.001
↑ Proteobacteria 0.57 0.60 2.23 0.41 0.030 — 0.013 —
Family
↓ Lactobacillaceae 79.19 67.50 56.75 18.83 <0.001 — 0.004 <0.001
↑ Lachnospiraceae 3.16 8.10 6.61 13.67 0.003 <0.001 0.007 0.007
↑ Bifidobacteriaceae 2.93 4.17 9.56 11.82 <0.001 0.044 <0.001 <0.001
= Ruminococcaceae 5.22 6.59 6.29 6.21 — — — —
↑ Veillonellaceae 0.74 3.72 2.42 10.91 <0.001 0.031 0.004 <0.001
↑ Prevotellaceae 1.16 1.60 3.76 9.15 <0.001 — 0.002 <0.001
↑ Coriobacteriaceae 0.32 1.30 2.29 5.96 <0.001 0.031 <0.001 <0.001
↑ Leptotrichiaceae 0.20 0.41 0.53 7.77 0.002 — — <0.001
= Uncl. Clostridiales 1.66 1.56 1.44 1.58 — — — —
↑ Tissierellaceae 1.14 0.29 1.23 3.04 <0.001 — 0.044 <0.001
↑ Aerococcaceae 0.03 0.24 1.51 2.07 <0.001 0.034 — <0.001
↑ Clostridiaceae 0.19 0.69 0.36 2.17 <0.001 0.009 — <0.001
= Bacteroidaceae 0.69 0.91 0.81 0.86 — — — —
= Streptococcaceae 0.42 0.50 1.05 0.55 — — — —
= Pasteurellaceae 0.03 0.10 1.46 0.02 — — — —
= Porphyromonadaceae 0.38 0.13 0.09 0.83 — — — —
↑ Gemellaceae 0.06 0.06 0.82 0.28 0.012 — 0.013 0.005
↑ Actinomycetaceae 0.06 0.09 0.10 0.53 0.010 — 0.029 0.006
↑ Peptostreptococcaceae 0.04 0.01 0.08 0.64 0.011 — 0.017 0.002
Genus
↓ Lactobacillus 79.16 67.45 56.69 18.80 <0.001 — 0.004 <0.001
↑ Gardnerella 2.72 3.65 7.68 11.44 <0.001 — 0.003 <0.001
↑ Prevotella 1.16 1.60 3.76 9.15 <0.001 — 0.002 <0.001
↑ Megasphaera 0.06 2.97 1.04 8.64 <0.001 0.001 0.036 <0.001
↑ Roseburia 1.09 4.42 3.51 3.51 <0.001 <0.001 <0.001 0.031
↑ Sneathia 0.18 0.41 0.53 7.76 <0.001 0.020 — <0.001
= Shuttleworthia 0.03 0.54 0.31 7.48 — — — —
↑ Faecalibacterium 1.49 2.31 2.14 2.09 0.027 0.003 0.041 —
↑ Atopobium 0.17 1.00 1.94 4.92 <0.001 0.024 0.001 <0.001
↑ Ruminococcaceae (other) 1.35 1.95 1.86 1.81 0.023 0.003 0.041 —
= Uncl. Clostridiales 1.66 1.56 1.44 1.58 — — — —
= Uncl. Ruminococcaceae 1.08 1.03 1.02 1.03 — — — —
↑ Aerococcus 0.03 0.24 1.50 2.06 <0.001 0.021 — <0.001
↑ Dialister 0.37 0.56 0.78 2.02 <0.001 0.011 <0.001 <0.001
↑ Clostridium 0.16 0.65 0.32 2.14 <0.001 0.008 — <0.001
↑ Bacteroides 0.69 0.91 0.81 0.86 — — — —
↑ Blautia 0.35 0.91 0.77 0.74 <0.001 <0.001 0.004 —
= Coprococcus 0.61 0.66 0.63 0.59 — — — —
↑ Streptococcus 0.40 0.49 1.04 0.54 0.045 0.012 0.013 —
= Oscillospira 0.65 0.56 0.53 0.58 — — — —
↑ Ruminococcus 0.54 0.58 0.59 0.56 — — — —
↑ Bifidobacterium 0.20 0.46 1.28 0.33 <0.001 <0.001 0.005 —
↑ Uncl. Lachnospiraceae 0.40 0.59 0.54 0.52 0.029 0.006 — —
= Parvimonas 0.20 0.07 0.17 1.39 <0.001 — — <0.001
= Peptoniphilus 0.35 0.15 0.13 1.09 — — — —
= Haemophilus 0.02 0.10 1.42 0.02 — — — —
↑ Uncl. Coriobacteriaceae 0.10 0.19 0.24 0.89 <0.001 0.023 0.017 <0.001
= Akkermansia 0.30 0.39 0.35 0.32 — — — —
= Anaerococcus 0.48 0.03 0.46 0.39 — — — —
↑ Escherichia 0.13 0.33 0.40 0.23 <0.001 <0.001 <0.001 —
= Porphyromonas 0.25 0.05 0.01 0.73 — — — —
↑ Ureaplasma 0.25 0.04 0.41 0.09 <0.001 0.001 — 0.005
Continued
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At a lower taxonomic level, Lactobacillaceae family (Kruskal-Wallis p-value < 0.001), almost totally rep-
resented by Lactobacillus genus, was found predominant in healthy women (79.2%), as well as in CT (67.5%) 
and VVC (56.7%) subjects, but profoundly and significantly depleted in BV subjects (18.8%). Lachnospiraceae, 
Bifidobacteriaceae, and Veillonellaceae families were differently represented across groups (Kruskal-Wallis 
p-values: p < 0.005 for all families, Table 2); in particular, they were significantly more abundant in all the patho-
logical conditions with respect to healthy women.
Analysing the vaginal microbiota composition at the genus level, the aforementioned progressive depletion 
in Lactobacillus genus from HC, to CT, VVC, and BV conditions was associated to a corresponding increase 
in the anaerobe genera Gardnerella, Prevotella, Megasphaera, Roseburia and Atopobium (all Kruskal-Wallis 
p-values < 0.001, Fig. 2b). With respect to HC vaginal microbiota composition, Gardnerella and Prevotella were 
found significantly increased in BV and VVC women only, whereas Megasphaera, Roseburia and Atopobium were 
significantly increased in CT subjects too. Moreover, Faecalibacterium was significantly increased in both CT 
and VVC, but not in BV. Finally, BV vaginal microbiota also showed a significant increase in Sneathia (Table 2). 
Notably, 4/20 women affected by BV showed the presence of Shuttleworthia at very high relative abundances 
(range: 29.1–41.5%), compared to an average of 0.23% in other samples. Among other bacteria, Mycoplasma was 
detected at very low relative abundance (0.07%) and resulted increased (p < 0.05) in BV with respect to HC and 
CT; Chlamydia, on the other hand, was detected only in CT subjects, as expected, although at a very low relative 
abundance (0.02%) (data not shown).
Species-level analysis. Because of the crucial importance of Lactobacillus species in the vaginal environ-
ment, a focus on this genus has been performed (Fig. 3). The Lactobacillus species-level analysis revealed that the 
vaginal microbiota of healthy subjects was dominated by L. crispatus for up to 61.0% of the total Lactobacillus 
sequences, while the shift towards a pathological condition was associated to a significant reduction in this spe-
cies abundance (p = 0.011), which represented 41.6% in CT infected women, 33.4% in VVC (p = 0.006 vs HC) 
and 28.5% in BV subjects (p = 0.005 vs HC). Such a depletion was reflected in a corresponding increase of L. 
iners in the shift from the healthy status (20.5%) to CT infection (42.1%), VVC (46.2%, p = 0.01 vs HC), and BV 
(56.7%, p = 0.009 vs HC). Interestingly, L. gasseri mainly characterized the VVC group (9.7%, p = 0.005 vs HC), 
whereas BV subjects showed the highest diversity of Lactobacillus species, including L. salivarius, L. helveticus, L. 
delbrueckii, and L. rhamnosus.
Besides the Lactobacillus species, the SPINGO-based bioinformatic analysis allowed to further refine the 
taxonomic classification of several bacterial genera found as differentially abundant in HC vs CT, VVC or BV 
comparisons. Identified species were Gardnerella vaginalis, Faecalibacterium prausnitzii, Megasphaera elsdenii, 
Atopobium vaginae, Shuttleworthia satelles and Chlamydia trachomatis. Sneathia genus comprised both S. amni-
onii and S. sanguinegens. Within Dialister genus, we detected D. succinatiphilus, plus other unidentified mem-
bers; Prevotella species included, among others, P. bivia, P. amnii, and P. timonensis; the majority (>97%) of 
Mycoplasma sequences were identified as M. hominis. Finally, no species-level characterization was obtained for 
Roseburia.
Taxonomic co-abundance clusters. To identify patterns of co-expression in vaginal microbiota, we estab-
lished co-abundant genera associations on the whole dataset and clustered them into five co-abundance groups 
(CAGs), whose names were assigned according to the most representative genera. Three groups resulted com-
posed by only one genus each, one of them being Lactobacillus, the major player in vaginal microbiota, the other 
two (i.e.: Clostridium and Finegoldia) being sub-dominant genera. Another group, named as Roseburia CAG, 
comprised several gut-specific commensal genera (e.g.: Faecalibacterium, Ruminococcus, Akkermansia), summing 
up to 14.2% of total relative abundance. The last group, namely Gardnerella CAG, included opportunistic genera 
(e.g.: Gardnerella itself, Atopobium, Megasphaera), averaging 19.3% of the total relative abundance (Suppl. Fig. 1).
In HC, Lactobacillus accounted for the vast majority of the relative abundance and was negatively correlated 
with all the other CAGs. In CT-affected women, on the other hand, an increase in Clostridium, Gardnerella 
Level Group
Relative abundance P-value
HC (%) CT (%) VVC (%) BV (%) Overalla CT vs. HCb VVC vs. HCb BV vs. HCb
Genus
↑ Peptostreptococcus 0.03 <0.01 0.08 0.63 0.018 — 0.024 0.009
↑ Finegoldia 0.09 0.03 0.45 0.16 0.016 — 0.015 —
↑ Veillonella 0.08 0.07 0.46 0.08 0.038 — 0.019 —
↑ Gemella 0.05 0.03 0.32 0.27 <0.001 — — <0.001
↑ Mobiluncus 0.03 0.08 0.02 0.49 0.013 — — 0.002
↑ Alloscardovia <0.01 0.06 0.57 <0.01 0.002 0.041 <0.001 —
↑ Uncl. Gemellaceae 0.01 0.03 0.49 <0.01 0.019 — — 0.041
= Uncl. Rs-045 <0.01 <0.01 0.04 0.43 — — — —
Table 2. Average relative abundances of main microbial groups (phylum, family, genus). For each taxa, significant 
p-values of the non-parametric Kruskal-Wallis test and of pairwise comparison (Dunn’s test) of women affected 
by Chlamydia trachomatis infection (CT), vulvo-vaginal candidiasis (VVC) or bacterial vaginosis (BV) versus 
healthy women (HC) are reported. Arrows indicate the direction of the variation with respect to HC: ↓, decreased; 
↑, increased; =, unchanged. aP-value of the Kruskal-wallis test for equal medians among groups. bP-value of the 
Dunn’s post-hoc test test for equal medians between each pathological condition (i.e.: CT, VVC or BV) and HC.
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and Roseburia CAGs, positively correlated one to each other, was observed. Moreover, in VVC, we detected an 
increase of Finegoldia and Gardnerella CAG, the latter showing a mixed (partly positive and partly negative) 
correlation to Roseburia CAG. Finally, in BV women, there was a substantial increase in Gardnerella CAG (which 
reflected that of many of its members), together with an increase of Clostridium and of the proportion of bacteria 
not belonging to any of the identified CAGs; notably, Roseburia and Gardnerella CAGs were negatively correlated, 
whereas Lactobacillus showed a moderate positive correlation to Roseburia CAG, indicating a consistent switch in 
the relationship between bacterial groups (Suppl. Fig. 2).
Vaginal metabolites composition for VVC-affected women and metabolite-microbiota corre-
lation. In this paper, we analyzed the metabolites composition of VVC samples by 1H-NMR, and compared 
it to the metabolomics data already obtained for the other groups20. Multiple comparison of metabolic profiles 
revealed a peculiar fingerprint of VVC-affected women, which resulted significantly separated from HC (p < 0.02 
on both Euclidean and Bray-Curtis distances) and from BV (p < 0.002 on both distances). No significant differ-
ences were found between VVC and CT groups (Fig. 4).
When compared to the healthy group, VVC metabolic profile resulted enriched (p < 0.05) in TMA-Nox 
(TMAO), taurine, and methanol, and, similarly to BV samples, in isopropanol, O-acetylcholine and glucose. 
In addition, significantly lower concentrations (p < 0.05) of lactate, 4-hydroxyphenylacetate, phenylalanine, 
pi-methylhistidine and glycine were detected in VVC and BV women; dimethylamine (DMA) and sarcosine were 
found significantly diminished in all pathological conditions compared to healthy subjects (Fig. 5).
Lactobacillus abundance was strongly positively associated with lactate and 4-hydroxyphenylacetate concentra-
tions (Spearman rank coefficient, ρ: 0.65 for both) and, to a lesser extent, to the concentration of several amino acids, 
such as isoleucine, leucine, tryptophan, phenylalanine and aspartate (ρ ranging from 0.28 to 0.58), DMA (ρ = 0.28), 
sarcosine (ρ = 0.54) and pi-methylhistidine (0.49). On the other hand, Lactobacillus abundance was negatively 
correlated to formate (ρ = −0.51), acetate (ρ = −0.67), 2-hydroxyisovalerate (ρ = −0.55) and alanine (ρ = −0.43) 
concentrations (Fig. 6). Other bacterial genera (i.e.: Gardnerella, Prevotella, Megasphaera, Atopobium, Dialister and 
Clostridium) showed a negative correlation with the aforementioned metabolites positively related to Lactobacillus, 
with coefficients ranging from −0.24 to −0.64, while they showed a positive correlation to organic acids (i.e.: for-
mate, pyruvate, propionate, acetate, 2-hydroxyisovalerate), amines (i.e.: TMA, putrescine), amino acids (i.e.: proline 
and alanine) and 5-aminopentanoate (ρ = 0.27–0.57). Finally, a third group of bacteria, including Roseburia, Blautia, 
Streptococcus and Bifidobacterium, was moderately positively correlated to TMAO and taurine (ρ = 0.24–0.33). All 
of these correlation coefficients were statistically significant (p < 0.05). Bacterial and metabolite-derived data were 
characterized by a very high and significant association, as demonstrated by Procrustes analysis (permutation-based 
p-value of m2 goodness-of-fit estimation <0.001) and RV coefficient (0.89, p < 0.001, for all phylogenetic levels).
Figure 3. Species-level characterization of Lactobacillus genus. Sequences classified within Lactobacillus genus 
were characterized down to species level by classifying them against a custom reference database. Proportions 
are relative to the total amount of Lactobacillus genus in each group. Only the twelve most-abundant species are 
represented. Less abundant Lactobacillus species are grouped under “Other Lactobacillus”. Per-sample relative 
abundances were averaged in each experimental category: (a) healthy (HC), (b) C. trachomatis (CT), (c) vulvo-
vaginal candidiasis (VVC) and (d) bacterial vaginosis (BV) positive women.
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Discussion
In this work, we investigated the modifications that take place in the vaginal microbiome and metabolome during 
common genital infections, namely VVC and CT infection, in comparison with the thoroughly studied condi-
tions corresponding to health and BV. Data generated by high-performing techniques, i.e. NGS and 1H-NMR 
spectroscopy, depicted in details the composition of the vaginal microbiome and metabolome and, notably, their 
correlations, in order to identify hallmarks of these common genital infections.
To the best of our knowledge, this paper analyzes in depth, for the first time, the vaginal microbiome and 
metabolome of VVC affected women. VVC represents the most frequent mucocutaneous mycosis caused by 
yeasts of the genus Candida, with a significant impact on women’s quality of life and associated medical costs, 
because of the high rate of recurrences and the increasing level of antifungal resistance21. In this context, a deep 
knowledge about the vaginal ecosystem during Candida infections could contribute to better understand VVC 
pathogenesis and to set up new strategies for its control.
According to the taxonomic and metabolomics analysis, we have found that each of the four conditions herein 
considered is characterized by a peculiar fingerprint.
Vaginal microbiota of HC was dominated, as expected, by members of the Lactobacillus genus and, in par-
ticular, by L. crispatus species. Lactobacillus showed a trend towards a decrease in CT women, associated to a sig-
nificant increase in Megasphaera, Atopobium, Faecalibacterium and Roseburia. The increase of Faecalibacterium 
prausnitzii in vaginal flora has already been recognized as a risk factor for C. trachomatis infection acquisition22. 
Similarly, Balle and colleagues found that some taxa were differentially abundant in the cervico-vaginal micro-
biota between C. trachomatis-infected and uninfected women, including G. vaginalis, A. vaginae, Dialister spp., 
Prevotella spp. and Megasphaera (all BV-associated bacteria)23.
On the other hand, microbiota of BV-affected women was characterized by a major shift in the relative 
abundance of many groups, such as Lactobacillus (decreased), Gardnerella, Prevotella, Megasphaera, Roseburia, 
Sneathia, and Atopobium (all increased). Increase of Mobiluncus was also observed, even if at a low relative abun-
dance (0.49% and 0.03% in BV and HC, respectively, p = 0.002), confirming evidences from Parolin et al.20. BV 
condition also presented a peculiar network of co-abundance among bacterial groups, as Lactobacillus was posi-
tively correlated to Roseburia CAG, which is, in turn, negatively correlated to Gardnerella group.
VVC microbiota profile was found as significantly altered, too, bearing many features in common with BV: all 
bacterial genera altered in BV, with the exception of Sneathia and with the addition of Faecalibacterium, showed 
a significant shift also in VVC, suggesting that Candida spp. infections reflect into a considerable modification 
of the vaginal ecology. Notably, Faecalibacterium and Roseburia, two major players in the healthy gut ecosystem, 
are associated in the vaginal environment to a proliferation of opportunistic microorganisms and to a general 
dysbiosis. It should be remembered that the gut could be the initial source of the vaginal colonisation by Candida 
spp., with the creation of a persistent intestinal reservoir of the yeast24. Thus, the presence of Faecalibacterium and 
Roseburia in the vaginal niche could reflect a general translocation of various microorganisms from the gastroin-
testinal tract to the vagina.
The trend towards the reduction of the relative abundance of L. crispatus and the corresponding increase 
of L. iners was found as another fingerprint of the ongoing dysbiosis in infectious conditions. L. crispatus has 
been reported to reduce the adherence of G. vaginalis and C. trachomatis to epithelial cells25, while L. iners 
has not26. A potential explanation lies in the fact that L. iners does not produce D-lactic acid, as well as H2O2, 
suggesting a lower protective ability against pathogens as compared to other Lactobacillus species27. Indeed, 
a L. iners-dominated community was associated with an increased risk for the acquisition of C. trachoma-
tis genital infections22. Similarly, an increase of non-H2O2-producing L. iners, with a contemporary decrease 
in H2O2-producing Lactobacillus species, has been observed in VVC-positive women28. Thus L. iners is 
Figure 4. Vaginal metabolome analysis. Principal Coordinates Analysis (PCoA) on Bray-Curtis distance 
showing the separation of the samples according to metabolite profile as obtained from 1H-NMR analysis 
of vaginal samples from healthy (HC), C. trachomatis (CT), vulvo-vaginal candidiasis (VVC) and bacterial 
vaginosis (BV) positive women. The first and second components of the total variance are shown.
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considered to be a transitional species, colonizing after perturbations of the vaginal environment, whereas a L. 
crispatus-predominant microbiota represents the hallmark of a healthy and stable vaginal status29,30.
Metabolome analysis by 1H-NMR spectroscopy provided a further explanation of the ongoing changes in gen-
ital infections as compared to HC. The production of lactic acid by Lactobacillus species, L. crispatus in particular 
(connected to the concentration of its conjugate base lactate), acidifies the pH in the vaginal environment, con-
tributing in keeping the environment in a homeostasis against growth of potentially harming microorganisms31. 
Lactic acid bacteria species are known producers of branched-chain amino acids32, thus the higher concentration 
of some of them, such as valine, leucine, and isoleucine, is another hallmark of the prevalence of lactobacilli in 
HC women.
On the other hand, the sharp decrease in lactate concentration in CT, VVC and BV, with the consequent increase of 
pH, is a marker of dysbiosis: the proliferation of diverse bacterial genera, some of them typical of the gut/fecal microbi-
ota31, is further associated to the increased presence of short-chain fatty acids, such as butyrate, propionate and acetate.
Figure 5. Metabolite concentration in vaginal samples. Bar plots showing metabolites concentrations per 
vaginal samples from healthy (HC), C. trachomatis (CT), vulvo-vaginal candidiasis (VVC) and bacterial 
vaginosis (BV) positive women. Each bar represents the median metabolite concentration (mmol/L) across 
replicates per experimental group. Error bars show inter-quartile range (i.e.: 75th–25th quantile). Metabolites are 
grouped according to biochemical type (panels a–f). Stars indicate significant differences vs HC group.
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Moreover, all three infection conditions are characterized by a significant reduction of DMA concentration, 
with a corresponding trend towards the increase of TMA (which reaches a significant level in BV), suggesting that 
vaginal dysbiosis impaired the balance between these two molecules belonging to the same pathway of choline 
degradation33.
In accordance with previous investigations7,20, we found that BV women are characterized by higher levels of 
biogenic amines and short-chain organic acids. Moreover, we reinforced the hypothesis of the role of Mycoplasma 
hominis in BV condition34, highlighted by both its increased relative abundance and the positive correlation 
between Mycoplasma and BV-related metabolites (e.g. formate, putrescine, propionate, acetate).
The vaginal metabolic profiles of CT-infected women show only slight modifications compared to healthy 
controls, being the reduction in some amino acids and biogenic amines the most significant variations. Presence 
of C. trachomatis was assessed only in CT subjects, as expected, at a low relative abundance, in accordance with its 
obligated intracellular localization in the upper genital tract, and not in the vaginal environment.
Other interesting data emerged from the investigation of the vaginal metabolic features in VVC-positive 
women, in particular the increased concentrations of vaginal glucose. High levels of glucose not only enhance the 
nutritive substrate of Candida, but also promote the expression of binding molecules in vaginal epithelial cells, 
thus increasing the adhesion of Candida35,36.
Notably, the higher levels of glucose found in VVC-positive women could by associated with the reduction 
of L. crispatus relative abundance in the vaginal environment. Indeed, it has been demonstrated that L. crispatus 
species shows a high metabolic activity in term of glucose consumption37.
During the switch from a commensal to a vaginal pathogen, Candida spp. produce various extracellular 
released enzymes, such as proteinases (Saps), phospholipases and hemolysins, that are implicated in adhesion, 
invasion and destruction of vaginal epithelial cells38. Some of the metabolic variations found in the vaginal eco-
system in VVC-positive women (e.g. higher levels of amino acids) could be ascribed to the tissue damage due to 
hydrolytic enzymes secreted by Candida.
In conclusion, in this paper, via 16S rRNA-based sequencing and 1H-NMR spectroscopy, we obtained deeper 
insights into the vaginal ecosystem of common infections of the female genital tract, such as VVC and C. tra-
chomatis infection, on both a taxonomic and metabolomics point of view. We found that women suffering from 
VVC and CT conditions were characterized by a vaginal microbiome positioning between eubiosis (healthy 
women) and dysbiosis (BV-positive subjects), with a depletion of lactobacilli and a corresponding increase in dif-
ferent anaerobe genera (e.g. Gardnerella, Prevotella, Megasphaera, Roseburia, Faecalibacterium and Atopobium). 
The changes in the bacterial communities occurring during the genital infections correlated to significant alter-
ations in the composition of vaginal metabolome, being the decrease of lactate concentration a common marker 
of all these infectious conditions.
Figure 6. Correlation between metabolome and microbiota. Heatmap showing the Spearman’s correlation 
coefficient between metabolites concentration and the relative abundances of the main bacterial genera. Only 
groups present at >1% of relative abundance in at least one sample were considered. Metabolite and microbial 
data were clustered using Pearson’s correlation metric and average linkage.
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From a clinical point of view, it has been already shown that several metabolites are significantly associated to 
BV clinical signs and symptoms, considering that this condition has strong metabolic signatures across multiple 
metabolic pathways39. Contrariwise, in VVC and CT infections, the quest for specific vaginal signatures (both 
taxonomic and metabolic) useful for clinical, diagnostic, or prognostic purposes is still an open issue. Our work 
sheds light on the less explored ecology of VVC and CT conditions, even if further investigations are needed to 
understand whether the microbial/metabolic alterations we identified precede the infection onset or if the path-
ogens themselves perturb the vaginal environment.
Methods
Study group and sample collection. Subjects included in this study are part of an enrolment occurred 
from January to July 2016 at the STI Outpatients Clinic of Sant’Orsola-Malpighi Hospital in Bologna (Italy). 
Samples collected during the enrolment were, partly, used for a first descriptive study of metabolome features in 
women affected by C. trachomatis infection. As previously described20, pre-menopausal heterosexual non-preg-
nant Caucasian women meeting the enrolment criteria (presence of urogenital symptoms or presence of risk 
factors for C. trachomatis infection) were included in the study and, then, subdivided in three groups on the 
basis of clinical and microbiological data. In particular, eligible women were allocated in one of the following 
groups: ‘Healthy’ (HC) (absence of symptoms and negative microbiological tests), ‘Bacterial Vaginosis’ (BV) (pos-
itivity for at least 3 out of 4 Amsel criteria, together with a Nugent score >3) and ‘Chlamydia’ (CT) (detection 
of C. trachomatis DNA by Versant CT/GC DNA 1.0 Assay; Siemens Healthineers, Tarrytown, NY, USA)40. In 
addition, a group of women suffering from vulvo-vaginal candidiasis (VVC) was included. VVC diagnosis was 
based on clinical symptoms (e.g. itching or vaginal whitish discharge), together with the microscopic and cul-
ture-based identification of Candida41. Samples were seeded on CHROMagar Candida Medium plates (Becton 
Dickinson, Franklin Lakes, NJ, USA) and incubated at 35 °C in aerobic atmosphere. The species identification 
of the grown yeast colonies was obtained by means of matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry (MALDI-TOF MS), using a Bruker Microflex MALDI-TOF MS instrument (Bruker 
Daltonics, Bremen, Germany). The presence of Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma 
genitalium was excluded by using the following molecular techniques: Versant CT/GC DNA 1.0 Assay (Siemens 
Healthineers), Aptima T. vaginalis and Aptima M. genitalium assays, Panther system (Hologic, Marlborough, MA, 
USA), respectively.
For all patients, demographic data and information about urogenital symptoms were recorded (Table 1) and 
two vaginal swabs were collected. The first one, collected by using E-swab collection system (Copan, Brescia, 
Italy) was used for microbiological diagnostic tests and BV assessment20. The second vaginal swab, collected 
with a sterile cotton bud and re-suspended in 1 ml of sterile saline, was centrifuged at 10,000 × g for 15 min. The 
obtained cell pellets were used for microbiome analysis, whereas the supernatants were employed for metabolome 
analysis, by means of 1H-NMR spectroscopy.
A written informed consent was obtained from all patients and the study protocol was approved by the Ethics 
Committee of Sant’Orsola-Malpighi Hospital, Bologna (7/2016/U/Tess). This study was carried out in accordance 
with the Declaration of Helsinki, following the recommendations of the Ethics Committee of the hospital.
Chlamydia trachomatis genotyping. In case of a CT positive result, the correspondent remaining eluate 
was recovered from PCR plate and used for CT molecular genotyping42 by omp1 gene semi-nested PCR followed 
by restriction fragment length polymorphism (RFLP) analysis, as previously described40. C. trachomatis serovar 
identification was achieved by the analysis of the specific restriction pattern.
DNA extraction and library preparation. Genomic DNA was isolated from vaginal cell pellets using 
a DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany). DNA concentration and quality were determined 
using a NanoDrop ND‐1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) and a 
TapeStation 2200 (Agilent Technologies, Santa Clara, CA, USA). The V3‐V4 hypervariable regions of the 16S 
ribosomal RNA (rRNA) gene were amplified according to the 16S Metagenomic Sequencing Library Preparation 
protocol (Illumina, San Diego, CA, USA) and sequenced on a MiSeq platform (Illumina), in a single 2 × 300 bp 
paired end run.
Vaginal microbiota profiling. 16S rRNA gene sequences were analyzed using PANDAseq (v. 2.5.0)43 
and discarding low quality reads (i.e.: showing stretches of bases with a Q-score < 3 for more than 25% of their 
length); then, reads were processed using the QIIME pipeline (release 1.8.0)44 and clustered into Operational 
Taxonomic Units (OTUs) at 97% identity level. Taxonomic assignment was performed using RDP classifier45 
against the Greengenes database (release 13.8; ftp://greengenes.microbio.me/greengenes_release/gg_13_8_otus), 
with a 0.5 identity threshold.
Species-level classification for all genera except Lactobacillus was performed by using SPINGO46 with default 
parameters. Characterization of Lactobacillus spp., on the other hand, was performed by BLAST-aligning all reads 
belonging to that genus to a custom reference database made up collecting all available reference sequences in 
NIH-NCBI database (ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/bacteria/) of 17 Lactobacillus species commonly 
found in the vaginal environment. Potential matches were filtered in order to retrieve an unequivocal classifica-
tion for each read.
Co-abundance network analysis was performed as previously described47, using Spearman’s correlation 
between taxa and building hierarchical clusters of co-abundant groups (CAGs) at genus level by Spearman’s cor-
relation metric and Ward linkage. Cytoscape (v 3.0)48 was used to graphically represent CAGs, as well as relative 
abundance of bacterial genera and strength of correlation. Additional details on species-level classification and 
CAG analysis can be found in Supplementary Methods.
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Biodiversity and distribution of the microorganisms were characterized via alpha- and beta-diversity evalua-
tions. Alpha-diversity was computed using Chao1, observed species, Shannon diversity and Faith’s Phylogenetic 
diversity (PD_whole_tree) metrics. Weighted and unweighted UniFrac distances were used for beta-diversity 
principal coordinates analysis (PCoA).
Metabolomic analysis. Metabolomic analysis was performed starting from 700 µl of the cell-free super-
natants of the vaginal swabs, added to 100 μl of a D2O solution of 3-(trimethylsilyl)-propionic-2,2,3,3-d4 acid 
sodium salt (TSP) 10 mM set to pH 7.0 by means of a 1 M phosphate buffer. 1H-NMR spectra were recorded at 
298 K with an AVANCE III spectrometer (Bruker, Milan, Italy) operating at a frequency of 600.13 MHz, equipped 
with Topspin software (Ver. 3.5)49. The signals originating from large molecules were suppressed by a CPMG 
filter of 400 echoes, generated by 180° pulses of 24 μs separated by 400 μs50. The signals were assigned by compar-
ing their multiplicity and chemical shift with Chenomx software data bank (ver 8.3, Chenomx Inc., Edmonton, 
Alberta, Canada). Separation among experimental groups on the basis of the metabolite profile was assessed via 
PCoA and “anosim” function on Bray Curtis and Euclidean distances between samples.
Statistical analysis. Statistical evaluation among alpha-diversity indices was performed by a non-parametric 
Monte Carlo-based test, using 9999 random permutations in QIIME suite. “adonis” function of the R package 
“vegan” (v. 2.0–10, https://cran.r-project.org/web/packages/vegan/index.html) with 9999 random permutations 
was employed to determine statistical separation of the microbiota profiles. Differences in abundances of bacterial 
taxa and metabolites among experimental groups were analyzed by Kruskal-Wallis, followed by Dunn’s post-hoc 
tests. Metabolite concentrations were correlated to bacterial composition by calculating Spearman’s correlation 
coefficient between metabolites and bacterial genera present ≥1% in at least 1 sample. Strength of association 
between metabolites and bacterial profiles were assessed by both RV coefficient51 and Procrustes analysis. For 
each statistical analysis, unless otherwise stated, p-values < 0.05 were considered as significant. Statistical analyses 
were performed using MATLAB software (Natick, MA, USA).
Data Availability
Raw reads are available in NCBI Short Read Archive (SRA, http://www.ncbi.nlm.nih.gov/sra) under accession 
number PRJNA523312.
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